News > Research buzz > Antibody levels vary according to vaccine type and previous infection with COVID-19

Antibody levels vary according to vaccine type and previous infection with COVID-19

Two doses of the Oxford-AstraZeneca COVID-19 vaccine induce lower levels of antibodies that are able to recognise and fight the SARS-CoV-2 Delta variant (B.1.617.2) than against other strains.

	1 Jul 2021
	United Kingdom
	Research buzz

To view this News Article please log in or create a profile

Login

Join

Similar stories

Blood cells in the bone marrow. Credit: Hector Huerga Encabo

Research buzz

Beneficial genetic changes observed in regular blood donors

Researchers at the Crick have identified genetic changes in blood stem cells from frequent blood donors that support the production of new, non-cancerous cells. More...

Colorised scanning electron micrograph of a T cell. Credit: NIAID

Water influx kicks immune cells into action

More...

Lung cancer cells can go ‘off grid’

Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop … More...

The researchers liken the dual role of CDKN2A to the ancient Roman god of transitions Janus,

Surprising ‘two-faced’ cancer gene role supports paradigm shift in predicting disease

Researchers from the Crick and Barts have shown that a genetic fault long believed to drive the development of oesophage… More...

Teaser image credit: Ernesto del Aguila III, NHGRI

Uncovering the role of Y chromosome genes in male fertility in mice

More...

Have your say

Share your story, opinions, ideas, news and more. Please submit your content below, which will be sent to a community manager and turned into a story for the website or content for an email newsletter

News category:

(At least 596 x 372 pixels and max. 2MB)